Identification and biology of β‐secretase
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
J. Neurochem. (2012) 120 (Suppl. 1), 55–61. Our knowledge of the etiology of Alzheimer’s disease (AD) has advanced tremendously since the discovery of amyloid beta (Aβ) aggregation in diseased brains. Accumulating evidence suggests that Aβ plays a causative role in AD. The β‐secretase enzyme, b eta‐site A PP c leaving e nzyme‐1 (BACE1), is also implicated in AD pathogenesis, given that BACE1 cleavage of amyloid precursor protein is the initiating step in the formation of Aβ. As a result, BACE1 inhibition has been branded as a potential AD therapy. In this study, we review the identification and basic characteristics of BACE1, as well as the progress in our understanding of BACE1 cell biology, substrates, and phenotypes of BACE1 knockout mice that are informative about the physiological functions of BACE1 beyond amyloid precursor protein cleavage. These data are crucial for predicting potential mechanism‐based toxicity that would arise from inhibiting BACE1 for the treatment or prevention of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“BACE1 is required for Aβ generation. Thus, it is a promising AD therapeutic target (reviewed in [44, 107]).”
From The Alzheimer’s β-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques (2013) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876
Self-citationCitron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., & Selkoe, D. J. (1992) · Nature · doi:10.1038/360672a0 · Cited by 1,757
Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity
Yan, R., Bienkowski, M. J., Shuck, M. E., Miao, H., Tory, M. C., Pauley, A. M., Brashler, J. R., Stratman, N. C., Mathews, W. R., Buhl, A. E., et al. (1999) · Nature · doi:10.1038/990107 · Cited by 1,438
Luo, Y., Bolon, B., Kahn, S., Bennett, B. D., Babu-Khan, S., Denis, P., Fan, W., Kha, H., Zhang, J., Gong, Y., et al. (2001) · Nature Neuroscience · doi:10.1038/85059 · Cited by 1,001
Self-citationRoher, A. E., Lowenson, J. D., Clarke, S., Wolkow, C., Wang, R., Cotter, R. J., Reardon, I. M., Zürcher-Neely, H. A., Heinrikson, R. L., & Ball, M. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53661-9 · Cited by 799
Roberds, S. L. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.12.1317 · Cited by 705
Control of Peripheral Nerve Myelination by the ß-Secretase BACE1
Willem, M., Garratt, A. N., Novak, B., Citron, M., Kaufmann, S., Rittger, A., DeStrooper, B., Saftig, P., Birchmeier, C., & Haass, C. (2006) · Science · doi:10.1126/science.1132341 · Cited by 703 · cited 2×
“For example, peripheral sciatic nerves and central optic nerves were hypomyelinated in BACE1 mice (Hu et al. 2006; Willem et al. 2006), and when injured, sciatic nerves were slow to remyelinate (Hu et al.”
BackgroundBace1 modulates myelination in the central and peripheral nervous system
Hu, X., Hicks, C. W., He, W., Wong, P., Macklin, W. B., Trapp, B. D., & Yan, R. (2006) · Nature Neuroscience · doi:10.1038/nn1797 · Cited by 608 · cited 2×
“For example, peripheral sciatic nerves and central optic nerves were hypomyelinated in BACE1 mice (Hu et al. 2006; Willem et al. 2006), and when injured, sciatic nerves were slow to remyelinate (Hu et al.”
BackgroundHaass, C., Lemere, C. A., Capell, A., Citron, M., Seubert, P., Schenk, D., Lannfelt, L., & Selkoe, D. J. (1995) · Nature Medicine · doi:10.1038/nm1295-1291 · Cited by 592
Laird, F. M., Cai, H., Savonenko, A. V., Farah, M. H., He, K., Melnikova, T., Wen, H., Chiang, H.-C., Xu, G., Koliatsos, V. E., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2766-05.2005 · Cited by 521
Maturation and Endosomal Targeting of β-Site Amyloid Precursor Protein-cleaving Enzyme
Huse, J. T., Pijak, D. S., Leslie, G. J., Lee, V. M.-Y., & Doms, R. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004175200 · Cited by 402
Cordy, J. M., Hussain, I., Dingwall, C., Hooper, N. M., & Turner, A. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1635130100 · Cited by 356
Depletion of GGA3 Stabilizes BACE and Enhances β-Secretase Activity
Tesco, G., Koh, Y. H., Kang, E. L., Cameron, A. N., Das, S., Sena-Esteves, M., Hiltunen, M., Yang, S.-H., Zhong, Z., Shen, Y., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.05.012 · Cited by 337 · cited 3×
“In the brains of AD patients, in which neuronal apoptosis may occur, the levels of GGA3 are significantly decreased (Tesco et al. 2007).”
Expression Analysis of BACE2 in Brain and Peripheral Tissues
Bennett, B. D., Babu-Khan, S., Loeloff, R., Louis, J.-C., Curran, E., Citron, M., & Vassar, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002688200 · Cited by 317
Self-citationMetabolism of the “Swedish” Amyloid Precursor Protein Variant in Neuro2a (N2a) Cells
Thinakaran, G., Teplow, D. B., Siman, R., Greenberg, B., & Sisodia, S. S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.16.9390 · Cited by 317
Benjannet, S., Elagoz, A., Wickham, L., Mamarbachi, M., Munzer, J. S., Basak, A., Lazure, C., Cromlish, J. A., Sisodia, S., Checler, F., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009899200 · Cited by 301
McConlogue, L., Buttini, M., Anderson, J. P., Brigham, E. F., Chen, K. S., Freedman, S. B., Games, D., Johnson-Wood, K., Lee, M., Zeller, M., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611687200 · Cited by 300 · cited 1×
“In addition, age-associated cognitive deficits were prevented in BACE1;APP bigenic mice (Luo et al. 2001, 2003; Ohno et al. 2004, 2007; Laird et al. 2005; Nishitomi et al. 2006; McConlogue et al. 2007; Kobayashi et al. 2008).”
BackgroundBACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice
Ohno, M., Cole, S. L., Yasvoina, M., Zhao, J., Citron, M., Berry, R., Disterhoft, J. F., & Vassar, R. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.12.008 · Cited by 290
Self-citationThe Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel β-Secretase (BACE1) Substrate
von Arnim, C. A. F., Kinoshita, A., Peltan, I. D., Tangredi, M. M., Herl, L., Lee, B. M., Spoelgen, R., Hshieh, T. T., Ranganathan, S., Battey, F. D., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414248200 · Cited by 258
BACE1 Deficiency Causes Altered Neuronal Activity and Neurodegeneration
Hu, X., Zhou, X., He, W., Yang, J., Xiong, W., Wong, P., Wilson, C. G., & Yan, R. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1334-10.2010 · Cited by 162
Vetrivel, K. S., Meckler, X., Chen, Y., Nguyen, P. D., Seidah, N. G., Vassar, R., Wong, P. C., Fukata, M., Kounnas, M. Z., & Thinakaran, G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808920200 · Cited by 153
Self-citationUbiquitin Regulates GGA3-mediated Degradation of BACE1
Kang, E. L., Cameron, A. N., Piazza, F., Walker, K. R., & Tesco, G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.092742 · Cited by 111
Proteomic identification of sorting nexin 6 as a negative regulator of BACE1‐mediated APP processing
Okada, H., Zhang, W., Peterhoff, C., Hwang, J. C., Nixon, R. A., Ryu, S. H., & Kim, T. (2010) · The FASEB Journal · doi:10.1096/fj.09-146357 · Cited by 102 · cited 1×
“negative regulator of BACE1 activity (Okada et al. 2010).”
Hitt, B. D., Jaramillo, T. C., Chetkovich, D. M., & Vassar, R. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-31 · Cited by 99
Self-citationMotonaga, K., Itoh, M., Becker, L. E., Goto, Y.-I., & Takashima, S. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00287-2 · Cited by 45
Research works printed but not linked: 59
- 10.1016/S0014-5793(00)01192-3 · DOI
- 10.1242/jcs.01422 · DOI · Paper page
- 10.1016/S0014-4886(03)00049-9 · DOI
- 10.1074/jbc.M005339200 · DOI · Paper page
- 10.1111/j.1460-9568.2010.07482.x · DOI
- 10.1038/85064 · DOI · Paper page
- 10.1074/jbc.M003202200 · DOI · Paper page
- 10.1016/0896-6273(95)90323-2 · DOI · Paper page
- 10.1042/BJ20070040 · DOI · Paper page
- 10.1074/jbc.M006947200 · DOI · Paper page
- 10.1074/jbc.M505249200 · DOI · Paper page
- 10.1074/jbc.M311601200 · DOI · Paper page
- 10.1073/pnas.160115697 · DOI · Paper page
- 10.1074/jbc.M110.170217 · DOI · Paper page
- 10.1046/j.1471-4159.1998.71051920.x · DOI · Paper page
- 10.1016/S0021-9258(18)53650-4 · DOI · Paper page
- 10.1074/jbc.270.11.6186 · DOI · Paper page
- 10.1074/jbc.M002095200 · DOI · Paper page
- 10.1016/S0014-5793(02)03052-1 · DOI · Paper page
- 10.1021/bi035199h · DOI
- 10.1038/nm1088 · DOI · Paper page
- 10.1074/jbc.M411296200 · DOI · Paper page
- 10.1371/journal.pone.0008477 · DOI · Paper page
- 10.1096/fj.08-106666 · DOI · Paper page
- 10.1006/mcne.1999.0811 · DOI · Paper page
- 10.1006/mcne.2000.0884 · DOI · Paper page
- 10.1074/jbc.M412938200 · DOI
- 10.1038/ncb1602 · DOI · Paper page
- 10.1242/jcs.00643 · DOI · Paper page
- 10.1073/pnas.241509198 · DOI · Paper page
- 10.1074/jbc.M206262200 · DOI · Paper page
- 10.1074/jbc.M409417200 · DOI · Paper page
- 10.1074/jbc.270.6.2419 · DOI
- 10.1016/j.neurobiolaging.2007.01.002 · DOI · Paper page
- 10.1016/S0021-9258(17)32449-3 · DOI · Paper page
- 10.1074/jbc.M700356200 · DOI · Paper page
- 10.1074/jbc.M310001200 · DOI · Paper page
- 10.1074/jbc.M303861200 · DOI · Paper page
- 10.1073/pnas.97.4.1456 · DOI · Paper page
- 10.1016/S0969-9961(03)00104-9 · DOI · Paper page
- 10.1046/j.1471-4159.2000.0752133.x · DOI · Paper page
- 10.1111/j.1460-9568.2006.05005.x · DOI
- 10.1111/j.1471-4159.2006.04178.x · DOI
- 10.1016/S0896-6273(03)00810-9 · DOI · Paper page
- 10.1006/mcne.2001.1065 · DOI
- 10.1016/j.mcn.2003.12.013 · DOI · Paper page
- 10.1126/science.1156609 · DOI · Paper page
- 10.1126/science.286.5443.1255a · DOI
- 10.1038/361260a0 · DOI · Paper page
- 10.1523/JNEUROSCI.5741-08.2009 · DOI · Paper page
- 10.1038/nn1531 · DOI · Paper page
- 10.1038/990114 · DOI · Paper page
- 10.1159/000015608 · DOI
- 10.1007/s12031-002-0007-5 · DOI
- 10.1016/j.mcn.2005.03.014 · DOI · Paper page
- 10.1074/jbc.M011116200 · DOI · Paper page
- 10.1074/jbc.M414648200 · DOI · Paper page
- 10.1074/jbc.M105583200 · DOI · Paper page
- 10.1074/jbc.271.49.31407 · DOI · Paper page
Cited by
Kandalepas, P. C., Sadleir, K. R., Eimer, W. A., Zhao, J., Nicholson, D. A., & Vassar, R. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1152-3 · Cited by 240
Self-citationYuan, J., Venkatraman, S., Zheng, Y., McKeever, B. M., Dillard, L. W., & Singh, S. B. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301659n · Cited by 135
Bace1 and Neuregulin‐1 cooperate to control formation and maintenance of muscle spindles
Cheret, C., Willem, M., Fricker, F. R., Wende, H., Wulf‐Goldenberg, A., Tahirovic, S., Nave, K., Saftig, P., Haass, C., Garratt, A. N., et al. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.146 · Cited by 124
Extracellular Vesicles in Brain Tumors and Neurodegenerative Diseases
Ciregia, F., Urbani, A., & Palmisano, G. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00276 · Cited by 110
“Aβ varies from 38 to 42 amino acids since γ-secretase catalyzes an imprecise cleavage (Selkoe and Schenk, 2003; Kandalepas and Vassar, 2012).”
BackgroundDrug development for Alzheimer’s disease: Review
Lao, K., Ji, N., Zhang, X., Qiao, W., Tang, Z., & Gou, X. (2019) · Journal of drug targeting · doi:10.1080/1061186x.2018.1474361 · Cited by 86
Metadata
- Authors
- Kandalepas, P. C., & Vassar, R.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2011-11-28
- Volume
- 120
- Issue
- s1
- Pages
- 55-61
- ISSN
- 0022-3042
- 1471-4159
- Cited by
- 74
- References
- 25
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.